Arbutus Biopharma(FRA) I9DN

Market Cap€866.57M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€4.30

-1.83%

-0.08Today

Arbutus Biopharma Financials at a Glance

Market Cap

€866.57M

Revenue (TTM)

€155.34

Net Income (TTM)

€130.77

EPS (TTM)

€0.67

P/E Ratio

6.54

Dividend

€0.00

Beta (Volatility)

-0.12 (Low)

Dividend

€0.00

Beta (Volatility)

-0.12 (Low)

Price

€4.30

Volume

Open

€4.30

Price

€4.30

Volume

Open

€4.30

Previous Close

€4.30

Daily Range

€4.30 - €4.30

52-Week Range

€3.04 - €4.51

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.12 (Low)

Price

€4.30

Volume

Open

€4.30

Previous Close

€4.30

Daily Range

€4.30 - €4.30

52-Week Range

€3.04 - €4.51

Estimated Earnings Date

N/A

I9DN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arbutus Biopharma

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Lindsay Androski, CFA, MBA

Website

www.arbutusbio.com

I9DN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

88.06%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

15.29%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€866.57M

Shares Outstanding

197.85M

Volume

Avg. Volume

695.546

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Arbutus Biopharma Performance Analysis

Arbutus Biopharma annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 37,126,502	299.4%
2023	2023-12-31	EUR 16,779,889	-54.8%
2024	2024-12-31	EUR 5,704,958	-66.0%
2025	2025-12-31	EUR 12,478,535	118.7%

Arbutus Biopharma annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -0.44	-37.8%
2023	2023-12-31	EUR -0.41	-7.3%
2024	2024-12-31	EUR -0.35	-14.2%
2025	2025-12-31	EUR -0.15	-55.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€0.87

+0.1%

Gross Profit

€0.86

+0.1%

Gross Margin

98.92%

+1.0%

Market Cap

€866.57M

N/A

Market Cap/Employee

€42.21

N/A

Employees

N/A

Net Income

-€4.42

-2.0%

EBITDA

-€4.94

-2.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€19.94

-44.8%

Total Debt

€3.17

+0.7%

Accounts Receivable

€0.32

+0.4%

Inventory

€0.00

N/A

Long Term Debt

€2.72

+0.7%

Short Term Debt

€0.45

+1.0%

Return on Assets

79.82%

-1.9%

Return on Invested Capital

-51.98%

+1.0%

Free Cash Flow

-€3.75

+0.4%

Operating Cash Flow

-€5.16

+0.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About I9DN

What is the current price of Arbutus Biopharma?

Arbutus Biopharma is trading at €4.30 per share.

What is the 52-week range for Arbutus Biopharma?

Over the past 52 weeks, Arbutus Biopharma has traded between €3.04 and €4.51.

How much debt does Arbutus Biopharma have?

As of the most recent reporting period, Arbutus Biopharma reported total debt of €3.17M.

How much cash does Arbutus Biopharma have on hand?

Arbutus Biopharma reported €16.77M in cash and cash equivalents in its most recent financial results.

What is Arbutus Biopharma’s dividend yield?

Arbutus Biopharma does not currently have a dividend yield.

Arbutus Biopharma(FRA) I9DN

Arbutus Biopharma Financials at a Glance

I9DN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Arbutus Biopharma

I9DN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Arbutus Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About I9DN

What is the current price of Arbutus Biopharma?

What is the 52-week range for Arbutus Biopharma?

How much debt does Arbutus Biopharma have?

How much cash does Arbutus Biopharma have on hand?

What is Arbutus Biopharma’s dividend yield?

Premium Investing Services